CIK 0001506492 · Non-accelerated filer<br>Smaller reporting company
Nuwellis, Inc.
Sign in to watch- Ticker
- NUWE
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680533453
- Phone
- 952-345-4200
- Business address
- 12988 VALLEY VIEW ROAD, EDEN PRAIRIE, MN, 55344
- Former names
- CHF Solutions, Inc., Sunshine Heart, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-28 | WALLER GREGORY D Director | Grant or award · Nonstatutory Stock Option (right to buy) | +6,744 | 6,744 | ||
| 2026-04-28 | Emerson Martin J Director | Grant or award · Nonstatutory Stock Option (right to buy) | +6,744 | 6,744 | ||
| 2026-04-28 | Feldshon Archelle Georgiou Director | Grant or award · Nonstatutory Stock Option (right to buy) | +6,744 | 6,744 | ||
| 2026-04-28 | McDonald David Director | Grant or award · Nonstatutory Stock Option (right to buy) | +6,744 | 6,744 | ||
| 2025-06-27 | ERB JOHN L CEO and President | Grant or award · Incentive Stock Option (right to buy) | +115,329 | 115,329 | ||
| 2025-06-10 | ERB JOHN L CEO and President | Conversion | +7,522 | $0.06 | $451 | 1,100,022 |
| 2025-06-09 | ERB JOHN L CEO and President | Conversion | +1,092,500 | $0.06 | $66K | 1,092,500 |
| 2025-06-09 | ERB JOHN L CEO and President | Other disposition · Series F Convertible Preferred Stock | −100 | 0 | ||
| 2025-06-09 | ERB JOHN L CEO and President | Other acquisition · Series F-1 Convertible Preferred Stock | +100 | 100 | ||
| 2025-06-09 | ERB JOHN L CEO and President | Conversion · Series F-1 Convertible Preferred Stock | −66 | 34 | ||
| 2025-05-20 | McCormick Michael Kendrick Director | Grant or award · Nonstatutory Stock Option (right to buy) | +17,496 | 17,496 | ||
| 2025-05-20 | Feldshon Archelle Georgiou Director | Grant or award · Nonstatutory Stock Option (right to buy) | +17,496 | 17,496 | ||
| 2025-05-20 | McDonald David Director | Grant or award · Nonstatutory Stock Option (right to buy) | +17,496 | 17,496 | ||
| 2025-05-20 | WALLER GREGORY D Director | Grant or award · Nonstatutory Stock Option (right to buy) | +17,496 | 17,496 | ||
| 2024-01-02 | McCormick Michael Kendrick Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,836 | 20,836 | ||
| 2024-01-02 | McDonald David Director | Grant or award · Nonstatutory Stock Option (right to buy) | +11,365 | 11,365 | ||
| 2024-01-02 | Feldshon Archelle Georgiou Director | Grant or award · Nonstatutory Stock Option (right to buy) | +11,365 | 11,365 | ||
| 2023-09-02 | Scott Robert Benjamin Chief Financial Officer | Grant or award · Incentive Stock Option (right to buy) | +18,643 | 18,643 | ||
| 2023-06-01 | McCormick Michael Kendrick Director | Grant or award · Non-qualified Stock Option (right to buy) | +1,967 | 1,967 | ||
| 2023-05-19 | WATSON WARREN S Director | Grant or award · Nonstatutory Stock Option (right to buy) | +2,146 | 2,146 |
Page 1 of 6 · 115 trades